Water-stable NaLuF4-based upconversion nanophosphors with long-term validity for multimodal lymphatic imaging
Jing Zhou1, Xingjun Zhu, Min Chen
1Department of Chemistry & Institute of Biomedicine Science & State Key Laboratory of Molecular Engineering of Polymers, Fudan University, 220 Handan Road, Shanghai 200433, PR China.
Biomaterials
|June 22, 2012
Summary
Multifunctional lanthanide-doped upconversion nanoparticles (Lu-UCNPs) offer stable, low-toxicity trimodal CT/MR/UCL imaging for biomedical applications. These nanoparticles demonstrate potential as a platform for next-generation multimodal imaging probes.
Area of Science:
- Biomedical Engineering
- Materials Science
- Nanotechnology
Background:
- Multimodal imaging combines strengths of different modalities to overcome individual limitations.
- Upconversion nanoparticles (UCNPs) are promising for bioimaging due to their unique optical properties.
Purpose of the Study:
- To synthesize multifunctional NaLuF(4)-based upconversion nanoparticles (Lu-UCNPs).
- To evaluate Lu-UCNPs as trimodal imaging agents for computed tomography (CT), magnetic resonance (MR), and upconversion luminescence (UCL) imaging.
- To assess the stability and biocompatibility of the synthesized Lu-UCNPs.
Main Methods:
- Facile one-step microemulsion synthesis of lanthanide-doped Lu-UCNPs (Gd(3+), Yb(3+), Er(3+)/Tm(3+)).
- Surface functionalization with sodium glutamate and diethylene triamine pentacetate acid (DTPA) for stability.
- In vitro characterization including transmission electron microscopy (TEM), methyl thiazolyl tetrazolium (MTT) assay, and histological analysis.
- Application in trimodal CT/MR/UCL lymphatic imaging in small animal models.
Main Results:
- Synthesized Lu-UCNPs exhibit high T1-enhancement, bright UCL emissions, and excellent X-ray absorption.
- The nanoparticles demonstrate excellent stability in water for over six months.
- Successful trimodal CT/MR/UCL lymphatic imaging was achieved in small animals.
- In vitro studies confirmed low toxicity of Lu-UCNPs.
Conclusions:
- The developed Lu-UCNPs are effective, stable, and low-toxicity multimodal agents for CT/MR/UCL imaging.
- This nanoparticle platform technology holds promise for developing next-generation multimodal imaging probes.

